Main > ONCOLOGY (**) > Carcinoid Syndrome Diarrhea *** > Treatment > Co: USA. L. Brand Telotristat Et.+

---

Co: USA. L. Brand Telotristat Et.+'s subsections
(*) EU Approval Date: 2017. 09.19
(*) USA Approval Date: 2017. 02.28
+Somatostatin Analogue
Company
Company Licensee WW (ex. JP & USA):
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2017. 09.19
TradeMark
TradeMark Web-Site
Tryptophan Hydroxylase Inhibition

Co: USA. L. Brand Telotristat Et.+'s products
This section has no products